By Kokab Rahman, Founder & CEO, Radeya Global
At the 33rd Annual Baron Investment Conference in New York on November 6, 2026, Elon Musk joined investor Ron Baron virtually for a wide-ranging fireside chat that laid out ambitious timelines and scale targets across his companies. Musk described a semiconductor manufacturing push aimed at producing one terawatt of AI chips annually—roughly 30 times his estimate of expected global AI chip output in 2027—through a phased Terafab project in Texas, while also projecting SpaceX’s annualized revenue run rate above $100 billion by December 2026 and annual recurring revenue potentially exceeding $500 billion by December 2027.
These figures represent Musk’s forward-looking assessments rather than audited results or firm commitments. He noted that the Terafab effort, which includes a research fabrication facility already under way at Gigafactory Texas in Austin for process iteration, would transfer successful techniques to a larger production site in Grimes County. The first phase has been previously associated with roughly $16.8 billion in investment, with the full long-term ambition potentially requiring far larger capital over time.
Musk also detailed StarMind, SpaceX’s planned constellation of space-based AI computing systems co-designed with NVIDIA. First launches of these orbital computers are targeted for the third quarter of 2027, with volume increasing in 2028 and substantially larger deployments in 2029. He argued that once launch costs fall sufficiently, placing compute in orbit becomes advantageous because of continuous solar power access and the physical limits on terrestrial data-center power and cooling.
Supporting infrastructure moves continue in parallel. On November 4, SpaceX selected Qualcomm to supply Dragonwing cellular infrastructure platforms—including Massive MIMO radio units—for Starlink Mobile’s planned U.S. terrestrial 5G network. Nationwide deployment of tens of thousands of sites is slated to begin in 2027 as SpaceX seeks to combine satellite connectivity with ground-based coverage.
On the robotics side, Tesla has begun early production of Optimus humanoid robots on a high-volume line at its Fremont factory. Units coming off the line have been described as the first meeting production-quality standards, though Musk has indicated that reaching rates on the order of 20,000 units per week will take at least a year and that external deliveries are targeted toward the end of 2027. At the Baron event he discussed a preference for a rental model and minimum productivity multiples relative to human labor.
Separately, Neuralink continues clinical work. On October 30 Musk stated that Blindsight, the company’s vision-related implant, is ready from an engineering standpoint and awaits regulatory approval; it previously received FDA Breakthrough Device Designation in 2024. Telepathy, focused on high-bandwidth thought-based communication, remains the first product. Recent updates have included speech-restoration progress, with one participant reaching 75 words per minute in early use.
For executives and businesses, these developments signal continued pressure on semiconductor capacity, power infrastructure, and telecommunications competition, alongside new partnership and supply-chain opportunities in AI hardware, orbital systems, and robotics. Job seekers in semiconductor process engineering, high-volume manufacturing, AI infrastructure, aerospace, and humanoid robotics may see expanded hiring as the companies attempt to execute at the stated scale. Realization depends on regulatory clearances, manufacturing yields, capital availability, and technical milestones that remain ahead.
